brimonidine tartrate has been researched along with Sciatica in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ignatowski, TA; Knight, PR; Spengler, RN; Sud, R | 1 |
1 other study(ies) available for brimonidine tartrate and Sciatica
Article | Year |
---|---|
Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release.
Topics: Adrenergic alpha-Agonists; Analysis of Variance; Animals; Brimonidine Tartrate; Clonidine; Dose-Response Relationship, Radiation; Electric Stimulation; Functional Laterality; Hippocampus; Hyperalgesia; In Situ Hybridization; In Vitro Techniques; Locus Coeruleus; Male; Norepinephrine; Pain Measurement; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sciatica; Tumor Necrosis Factor-alpha | 2007 |